60
Participants
Start Date
September 9, 2025
Primary Completion Date
April 5, 2026
Study Completion Date
April 5, 2026
KarXT
Specified dose on specified days
Midazolam
Specified dose on specified days
Fexofenadine
Specified dose on specified days
Digoxin
Specified dose on specified days
Local Institution - 0001, Lenexa
Lead Sponsor
Karuna Therapeutics
INDUSTRY